YD Bio Limited

US$5.97As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:YDESHealthcare
Country USA
PE (Fwd) •••
TSR 6Y CAGR (8.67%)
Div yield —
ROE —
Biotechnology
Beta (5Y) (0.12)
PE TTM 1,362
TSR TTM (47.77%)
Mkt cap US$422.9M
ROIC (360.63%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$6.04
1.10%
(86.67%)
Hold 9|3|4|9|4
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.12
0.12
0.11
0.11
22.87%
15.41%
14.68%
5.78%
Revenue$M
19.58
20.15
20.31
20.42
7.31%
10.08%
6.44%
3.90%
Peers (US$422.9M)
Cap (US$)
PE
439.6M
29.51x
423.0M
—
Capital
TTM
5Y
10Y
Leveragex
2.758
0.528
0.431
EBIT/Intx
1.084
0.388
0.373
Own earn%
15.11
48.21
35.64
Sh yield%
53.44
32.81
31.13
Owners
Insiders/Inst%
6.64
21.88
Short interest%
5.39
SBC / revenue%
5.04
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
8–14
$1 testx
—
Incr. ROIC%
7